PUBLICATION
            Ethanolic Extract of Fructus Alpinia oxyphylla Protects Against 6-Hydroxydopamine-Induced Damage of PC12 Cells In Vitro and Dopaminergic Neurons in Zebrafish
- Authors
 - Zhang, Z.J., Cheang, L.C., Wang, M.W., Li, G.H., Chu, I.K., Lin, Z.X., and Lee, S.M.
 - ID
 - ZDB-PUB-110713-62
 - Date
 - 2012
 - Source
 - Cellular and molecular neurobiology 32(1): 27-40 (Journal)
 - Registered Authors
 - Keywords
 - fructus Alpina oxyphylla, neuroprotection, Parkinson's disease, zebrafish, PC12 cell
 - MeSH Terms
 - 
    
        
        
            
                
- Cytoprotection/drug effects*
 - Larva/drug effects
 - Larva/growth & development
 - Larva/physiology
 - PC12 Cells
 - Zebrafish/embryology
 - Zebrafish/growth & development
 - Embryo, Nonmammalian
 - Animals
 - Locomotion/drug effects
 - Ethanol/pharmacology
 - Dopaminergic Neurons/drug effects*
 - Dopaminergic Neurons/physiology
 - Plant Extracts/chemistry
 - Plant Extracts/pharmacology*
 - Rats
 - Behavior, Animal/drug effects
 - Cell Death/drug effects
 - Oxidopamine/toxicity*
 
 - PubMed
 - 21744117 Full text @ Cell. Mol. Neurobiol.
 
            Citation
        
        
            Zhang, Z.J., Cheang, L.C., Wang, M.W., Li, G.H., Chu, I.K., Lin, Z.X., and Lee, S.M. (2012) Ethanolic Extract of Fructus Alpinia oxyphylla Protects Against 6-Hydroxydopamine-Induced Damage of PC12 Cells In Vitro and Dopaminergic Neurons in Zebrafish. Cellular and molecular neurobiology. 32(1):27-40.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                In an attempt to understand the neuroprotective effect of Fructus Alpinia oxyphylla (AOE) and to elucidate its underlying mechanism of action, the ethanolic extract of AOE was investigated using zebrafish
            and PC12 cell models. AOE prevented and restored 6-hydroxydopamine (6-OHDA)-induced dopaminergic (DA) neuron degeneration
            and attenuated a deficit of locomotor activity in a zebrafish (Danio rerio) model of Parkinson’s disease (PD). Treatment with AOE increased the viability of 6-OHDA-treated PC12 cells in vitro in a
            dose-dependent manner by attenuating cellular apoptosis. However, protocatechuic acid (PCA) and chrysin, two known polyphenol
            components of AOE, could not reproduce the neuroprotective activity of AOE in the PD zebrafish or PC12 cell models. A mechanistic
            study found that the protective effect of AOE against 6-OHDA-induced neuronal injury involved anti-inflammatory action (down-regulation
            of gene expression of IL-1β and TNF-α) and anti-oxidative action (inhibition of NO production and iNOS expression in PC12
            cells). Moreover, the PI3K-AKT pathway might be part of the mechanism of neuroprotection of AOE. The results of this research
            are expected to provide a scientific rationale for the use of AOE in the treatment of PD. However, it is important that the
            active components that contribute to the neuroprotective action of AOE are identified and characterized.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping